Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02548884
Other study ID # Difficult cannulation
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2015
Est. completion date December 30, 2020

Study information

Verified date May 2021
Source Helsinki University Central Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to compare two different techniques (pancreatic sphincterotomy (PS) and double wire technique (DGW)) regarding the risk of post-ERCP pancreatitis (PEP) and the success of cannulation in difficult cannulation. For the study, the difficult cannulation is de-fined as situation when the common bile duct has not been cannulated in five minutes, after five attempts or after two pancreatic guide wire passages or when any of those limits is exceeded. The two techniques, the PS and the DGW, will be compared in random fashion. The primary end-point is the risk of PEP .


Recruitment information / eligibility

Status Completed
Enrollment 1190
Est. completion date December 30, 2020
Est. primary completion date September 30, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Naive papilla, ERCP indication common bile duct cannulation Exclusion Criteria: - No consent to the study - Ongoing pancreatitis

Study Design


Related Conditions & MeSH terms

  • Endoscopic Retrograde Cholangiopancreatography

Intervention

Procedure:
Biliary cannulation


Locations

Country Name City State
Finland Helsinki University Hospital Helsinki

Sponsors (3)

Lead Sponsor Collaborator
Helsinki University Central Hospital Oulu University Hospital, Turku University Hospital

Country where clinical trial is conducted

Finland, 

References & Publications (1)

Halttunen J, Meisner S, Aabakken L, Arnelo U, Grönroos J, Hauge T, Kleveland PM, Nordblad Schmidt P, Saarela A, Swahn F, Toth E, Mustonen H, Löhr JM. Difficult cannulation as defined by a prospective study of the Scandinavian Association for Digestive Endoscopy (SADE) in 907 ERCPs. Scand J Gastroenterol. 2014 Jun;49(6):752-8. doi: 10.3109/00365521.2014.894120. Epub 2014 Mar 14. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Post ERCP pancreatitis defined by ESGE guidelines published 2014 Acute pancreatitis within 48 hours post ERCP. Post-ERCP pancreatitis (PEP) is defined as the presence of abdominal pain attributable to acute pancreatitis, together with a need for an unplanned hospitalization or an extension of a planned hospitalization by at least 2 days, and a serum /plasma amylase at least 3 times above the upper limit of normal at 24 hours after the procedure. 48 hours
Secondary Biliary cannulation success within 15 minutes after randomization After randomization, timing to get the wire in biliary duct. First assessed the number of procedures succeeded in 15 minutes. 15 minutes
Secondary Biliary cannulation success, total number The total number of successful biliary cannulations after randomization 2 hours
See also
  Status Clinical Trial Phase
Completed NCT04325152 - Clip-assisted Fixation to Prevent Migration of Fully Covered Self-expandable Metal Stent in Patients Undergoing ERCP N/A
Completed NCT01505218 - Propofol Patient-controlled Sedation for Endoscopic Retrograde Cholangiopancreatography N/A
Completed NCT00867204 - Short Versus Long Wire ERCP Systems N/A
Completed NCT03707613 - Learning Curve of Double-wire Cannulation Technique During Endoscopic Retrograde Cholangiopancreatography (ERCP) N/A
Withdrawn NCT03353181 - Application of Endoscopic Scissors Cutting ENBD Tube in the Treatment of Malignant Hilar Biliary Strictures N/A
Completed NCT05122858 - EUS-guided Biliary Drainage of First Intent With the Lumen Apposing Metal Stent vs. ERCP in the Management of Malignant Distal Biliary Obstruction (AXIOS-CPRE) N/A
Completed NCT03550768 - Effect of Anatomy of Major Duodenal Papilla on the Difficulty of Cannulation During Endoscopic Retrograde Cholangiopancreatography
Recruiting NCT04903444 - Development and Validation of an Artificial Intelligence-based Biliary Stricture Navigation System in MRCP-based ERCP N/A
Completed NCT04103749 - Global Prospective Case Series Using a Single-Use Duodenoscope N/A
Completed NCT04609917 - Difficult Cannulation Criteria in Trainee Involved ERCP Cannulation
Recruiting NCT05947461 - Prevention of Post-ERCP Pancreatitis by Indomethacin vs Diclofenac N/A
Completed NCT04143698 - Reusable Versus Disposable Duodenoscopes for ERCP N/A
Completed NCT02992652 - Allopurinol in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis N/A
Completed NCT01079312 - Patient-controlled Sedation With Propofol and Remifentanyl for Endoscopic Retrograde Cholangiopancreatography (ERCP) Phase 4
Completed NCT04223830 - Initial Case Series With Exalt Single-Use Duodenoscope - Expanded User Experience N/A
Recruiting NCT06277414 - a Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Complication
Completed NCT06388525 - Post-ERCP Cholecystectomy. How ERCP and ERCP-related Variables Effect the Outcomes?
Recruiting NCT03413111 - Modified Double Wire Technique to Facilitate the Successful Cannulation N/A
Terminated NCT03057769 - Effect of Papillary Epinephrine Spraying on Post-ERCP Pancreatitis in Patients Received Rectal Indomethacin N/A
Recruiting NCT01745978 - Compare the Knob-tipped Knife With the Needle Knife in Difficult Biliary Cannulation Phase 3